Steven Cohen Satsuma Pharmaceuticals, Inc. Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$4.8 - $7.25 $2.54 Million - $3.83 Million	-528,169 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.57 - $7.18 $2.41 Million - $3.79 Million	528,169 New	528,169 $2.97 Million
Q3 2020 Nov 16, 2020	SELL	$3.85 - $28.47 $241,067 - $1.78 Million	-62,615 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$16.01 - $34.69 $1 Million - $2.17 Million	62,615 New	62,615 $1.8 Million

Ticker STSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,587,500
Description
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.